Lung and sarcoma tumor xenografts were shown to be susceptible to siRNA polyplexes against factors that control tumor angiogenesis (ETV-2 and MYCT1) and the immunosuppressive tumor microenvironment [170,171]. Here, ETV2 is linked to neoplasm.